LAZZARI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 2.314
AS - Asia 1.480
EU - Europa 1.410
AF - Africa 24
SA - Sud America 21
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 10
Totale 5.277
Nazione #
US - Stati Uniti d'America 2.241
CN - Cina 814
IT - Italia 433
DE - Germania 203
JP - Giappone 145
SG - Singapore 136
GB - Regno Unito 130
FR - Francia 126
IN - India 115
IE - Irlanda 78
ES - Italia 57
SE - Svezia 57
CA - Canada 53
FI - Finlandia 52
KR - Corea 50
HK - Hong Kong 48
NL - Olanda 39
TR - Turchia 36
PL - Polonia 32
BE - Belgio 29
UA - Ucraina 27
VN - Vietnam 27
TW - Taiwan 26
AT - Austria 23
ID - Indonesia 22
GR - Grecia 19
MX - Messico 19
RO - Romania 16
AU - Australia 15
PT - Portogallo 15
CH - Svizzera 14
TH - Thailandia 14
CZ - Repubblica Ceca 11
DK - Danimarca 9
NO - Norvegia 9
BR - Brasile 8
IR - Iran 8
MY - Malesia 8
RU - Federazione Russa 8
MA - Marocco 7
EU - Europa 6
HU - Ungheria 6
IL - Israele 6
SN - Senegal 6
AM - Armenia 5
AR - Argentina 5
NG - Nigeria 5
SI - Slovenia 5
AP - ???statistics.table.value.countryCode.AP??? 4
CY - Cipro 4
SA - Arabia Saudita 4
BG - Bulgaria 3
CO - Colombia 3
EC - Ecuador 3
EG - Egitto 3
NZ - Nuova Zelanda 3
IS - Islanda 2
LB - Libano 2
LT - Lituania 2
MO - Macao, regione amministrativa speciale della Cina 2
PK - Pakistan 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CU - Cuba 1
DZ - Algeria 1
EE - Estonia 1
LA - Repubblica Popolare Democratica del Laos 1
PE - Perù 1
PH - Filippine 1
TN - Tunisia 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 5.277
Città #
Ann Arbor 220
Fairfield 177
Beijing 172
Chandler 128
Redwood City 123
Houston 111
Singapore 111
Shanghai 106
Santa Clara 92
Ashburn 80
Woodbridge 78
Seattle 72
Cambridge 70
Wilmington 67
Dublin 66
Torino 52
Guangzhou 43
Pisa 42
Tokyo 42
Milan 36
Nanjing 36
Dearborn 34
Hangzhou 31
Warsaw 28
San Diego 27
Turin 27
Villeurbanne 24
Nyköping 22
Berlin 21
Dong Ket 20
New York 20
Jakarta 19
Medford 19
Columbus 18
Mumbai 17
Boston 16
Jacksonville 16
Naples 16
Norwalk 16
Paris 16
Lappeenranta 15
Munich 15
Ottawa 15
Pune 15
Rome 15
Toronto 15
Vienna 15
Wuhan 15
Boardman 14
Chongqing 14
Princeton 14
Xian 14
Hyderabad 13
Kunming 13
Los Angeles 13
Phoenix 13
Amsterdam 12
Barcelona 12
Brussels 12
Chengdu 12
Duncan 12
Taipei 12
Zhengzhou 12
Helsinki 11
Hong Kong 11
Tianjin 11
Istanbul 10
La Jolla 10
Nanchang 10
Nutley 10
Bangkok 9
Buffalo 9
Chennai 9
London 9
Shenzhen 9
Silver Spring 9
Utrecht 9
Xiamen 9
Atlanta 8
Fremont 8
Hefei 8
Nashville 8
Oxford 8
Poughkeepsie 8
San Mateo 8
Seoul 8
Carlow 7
Central 7
Geumcheon-gu 7
Izmir 7
Novara 7
Oslo 7
Raleigh 7
Rochester 7
St Louis 7
Stuttgart 7
Arlington 6
Baltimore 6
Bangalore 6
Chicago 6
Totale 2.946
Nome #
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer 1.390
MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations 1.166
Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer 540
Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer 461
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer 301
Met-driven invasive growth involves transcriptional regulation of Arhgap12 232
Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis 225
Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer 200
Ron kinase transphosphorylation sustains MET oncogene addiction 193
RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells. 168
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer 132
An 'in-cell trial' to assess the efficacy of a monovalent anti-MET antibody as monotherapy and in association with standard cytotoxics. 111
Tumor heterogeneity and Lesion-Specific response to targeted therapy in colorectal cancer 94
The ROR1 pseudokinase diversifies signaling outputs in MET-addicted cancer cells. 87
223P Artificial intelligence-based pathomics biomarker predict primary resistance to first-line treatment in metastatic colorectal cancers 29
PO-050 A molecularly annotated platform of pdx-derived cell lines mirrors the genomic landscape of colorectal cancer 19
Abstract B33: The oligoclonal antibody MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancer cells harboring EGFR extracellular domain mutations 15
Abstract LB-299: A comprehensive platform of patient-derived xenografts and matched cell lines mirrors the genomic landscape of colorectal cancer 14
Abstract 3588: Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer 2
Totale 5.379
Categoria #
all - tutte 10.666
article - articoli 0
book - libri 0
conference - conferenze 409
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.075


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020489 0 0 0 0 0 79 58 78 88 62 69 55
2020/2021775 48 25 50 66 63 61 92 47 71 91 58 103
2021/2022857 85 79 102 112 43 45 75 54 66 51 84 61
2022/2023679 60 71 39 56 50 90 46 46 69 35 55 62
2023/2024691 65 77 50 44 80 37 43 43 19 88 61 84
2024/2025515 46 73 67 90 147 92 0 0 0 0 0 0
Totale 5.379